The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Looking for ways to monetize skills quickly? Turn your talents into cash and start earning today with these strategies.
17,417 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Oil prices near $100 a barrel collide with Brazil's sugar-and-ethanol balance, threatening tighter sugar supplies jus...
MP Materials is at the center of America’s push to secure essential minerals. This guide breaks down whether now is t...
A new partnership could let borrowers pledge crypto as collateral for home loans. This article breaks down how crypto...
Lucid has built a reputation for rapid delivery gains, echoing early EV winners. This deep dive explains why the stoc...
Celebrity moments spark conversations that reach far beyond TV screens. This personal finance guide decodes how steph...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
AGNC Investment's dividend yield may catch your eye, but a high number isn’t the whole story. This guide breaks down ...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
Two under-the-radar oil stocks could become big movers. This guide shows how to spot overlooked stocks before they so...
Retirees face rising costs that squeeze fixed incomes. This guide offers simple, actionable steps—from inflation-focu...